Skip to content

A Rapid Clinical Care Pathway to Care for Patients Affected by Chronic Constipation

Guideline to Implementation: A Rapid Clinical Care Pathway to Care for Patients Affected by Chronic Constipation- Phase 2

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07032376
Enrollment
109
Registered
2025-06-24
Start date
2025-08-20
Completion date
2027-02-01
Last updated
2026-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Constipation

Keywords

Questionnaires, Gastroenterology care, Rectal Expulsion Device (RED)

Brief summary

This research is studying how the availability of a Food and Drug Administration (FDA)-cleared point-of-care, bedside device bedside device called Rectal Expulsion Device (RED) can be used to evaluate constipation in the participants' routine office visit with the participants' care provider. In this research, participants will be asked to complete a survey prior to the gastroenterology office consultation. Health-related information will be collected for this research study. There are no additional study visits for this research study.

Detailed description

This registration is (Implementation Phase) for the registered study "Guideline to Implementation: A Rapid Clinical Care Pathway to Care for Patients Affected by Chronic Constipation" (Observational Phase) NCT06352827.

Interventions

BEHAVIORALSurvey

All participants will complete a baseline survey and have medical information collected.

BEHAVIORALRectal Expulsion Device use

During the participant's clinic visit for constipation, the Rectal Expulsion Device will be available for the gastroenterology care provider to use if the decision is made to use this during the clinic visit. In addition, the care provider will have access to the RED brochure and the Michigan Chart (MICHART) Our Practice Advisory (OPA) - a decision support tool in MiChart to support care navigation using RED.

Sponsors

University of Michigan
Lead SponsorOTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Participants: \- Participant has Chronic constipation as a main symptom

Exclusion criteria

Participants: * Participant has taken narcotic pain medication in the past 30 days * Participant has been scheduled for a test called an anorectal manometry in the past 12 months * Participant has been scheduled to see a pelvic floor physical therapist in the past 12 months * Participant is pregnant

Design outcomes

Primary

MeasureTime frameDescription
Percentage of encounters in which anorectal physiology testing is ordered or performed at the baseline routine-care gastroenterology office appointmentDay 1 (Baseline = initial appointment after consent)]Fidelity to ordering pelvic floor diagnostics
Percentage of encounters in which pelvic floor physical therapy is ordered at the baseline routine-care gastroenterology office appointmentDay 1 (Baseline = initial appointment after consent)]Fidelity to ordering pelvic floor treatment

Countries

United States

Contacts

PRINCIPAL_INVESTIGATOREric Shah, MD

University of Michigan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 7, 2026